John L Flavin

Bio

John has 20 years of experience in the life sciences field focused on finance and operations. John has led two successful NASDAQ IPOs, raised over $230 million in private and public funding and has served as a board member and COO/CFO role in a public company setting for the past 11 years. Most recently, John served as President, Chief Financial Officer and Director for Advanced Life Sciences Holdings, Inc. (ADLS). He helped to found ADLS and led its IPO in 2005 and subsequent follow-on equity offerings. John supervised all business, financial and operational activities of ADLS. Prior to ADLS, John helped found MediChem Life Sciences, Inc. (MCLS) and built the company from 6 people in 1991 to over 230 by 2002. He helped lead the MCLS private equity financing in 1999, successful initial public offering in 2000 and its acquisition by DeCODE genetics, Inc. in 2002. Mr. Flavin was the COO and a director of MCLS and was responsible for the acquisition and management of Emerald Biostructures, ThermoGen and AXAS which became subsidiaries of MCLS. John was named the Marquette University College of Business Young Alumnus of the Year in 2005 and is a KPMG Illinois High Tech Award winner. Mr. Flavin serves on the Lewis University President’s Council of Regents and is a Marquette Circles Host Committee Member. He guest lectures regularly at the University of Chicago Booth Graduate School of Business in the area of biotechnology entrepreneurship.